Indeed, immune cells isolated from peripheral blood of patients with glioblastoma exhibit more CD4+/CD25+/FOXP3+ Treg cells relative to those of patients without glioblastoma [149,150,151,152,153]. This evidence concerns the gene CD4 and glioblastoma.